본문 바로가기
KERD
논문KCI 등재

청대 의약시장의 변화와 ‘가짜 약’ 논란

Changes in pharmaceutical market and “fake drug” problem in the Qing period

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류역사학

초록

Since ancient times, fake drugs have been on the market in Chinese society. However, during the Ming-Qing Dynasty, this problem intensified as the size of the pharmaceutical market grew, the collection and distribution structure of pharmaceutical products became increasingly complex, and the phenomenon of separation between the prescription and distribution of drugs advanced. Additionally, the government did not manage the manufacturing or quality of drugs and there was no law or institution designed to solve the problem of fake drugs. Furthermore, social opinion also criticized the widespread problem of fake drugs, and patients and doctors had to rely on various pharmacognostic books and medical knowledge to find reliable drugs in the drug market. Meanwhile, as merchants participated and invested commercial capital in the pharmaceutical industry, large reputable pharmacies began to emerge in large cities and produced drugs. With the commercialization of the pharmaceutical market, the public gained interest in drugs and consumed drugs produced by these pharmacies. Moreover, there were frequent problems in the market as fake drugs imitating popular drugs were distributed and the names of famous pharmacies were stolen. Although fake drugs were a universal social problem, the Qing government was reluctant to strictly control them tried to solve this issue by enforcing banning and punishment through local governments. Prominent pharmacies filed several lawsuits against the government over the theft of fake drugs and drug names. They also advertised the legitimacy and authenticity of drugstore to the public and customers. Doctors and merchants responded to the problem of fake drugs by following occupational morality, developing drug discrimination, cracking down on organizational discipline, filing complaints with government offices, and advertising their authenticity. However, the fake medicines did not easily disappear despite such a response, as there was no state control or legislation. Evidently, the pharmaceutical market was already highly commercialized and its structure were complex. Moreover, the financial benefits of fake drugs, competition in the pharmaceutical market, and public demand for drugs with similar effects at low prices also affected the popularity of fake drugs. Hence, the distribution of fake medicine in the Qing society can be seen as a phenomenon of separation between the prescription and distribution of drugs, commercialization and consumption of drugs, and competition on the medical market.

Abstract

Since ancient times, fake drugs have been on the market in Chinese society. However, during the Ming-Qing Dynasty, this problem intensified as the size of the pharmaceutical market grew, the collection and distribution structure of pharmaceutical products became increasingly complex, and the phenomenon of separation between the prescription and distribution of drugs advanced. Additionally, the government did not manage the manufacturing or quality of drugs and there was no law or institution designed to solve the problem of fake drugs. Furthermore, social opinion also criticized the widespread problem of fake drugs, and patients and doctors had to rely on various pharmacognostic books and medical knowledge to find reliable drugs in the drug market. Meanwhile, as merchants participated and invested commercial capital in the pharmaceutical industry, large reputable pharmacies began to emerge in large cities and produced drugs. With the commercialization of the pharmaceutical market, the public gained interest in drugs and consumed drugs produced by these pharmacies. Moreover, there were frequent problems in the market as fake drugs imitating popular drugs were distributed and the names of famous pharmacies were stolen. Although fake drugs were a universal social problem, the Qing government was reluctant to strictly control them tried to solve this issue by enforcing banning and punishment through local governments. Prominent pharmacies filed several lawsuits against the government over the theft of fake drugs and drug names. They also advertised the legitimacy and authenticity of drugstore to the public and customers. Doctors and merchants responded to the problem of fake drugs by following occupational morality, developing drug discrimination, cracking down on organizational discipline, filing complaints with government offices, and advertising their authenticity. However, the fake medicines did not easily disappear despite such a response, as there was no state control or legislation. Evidently, the pharmaceutical market was already highly commercialized and its structure were complex. Moreover, the financial benefits of fake drugs, competition in the pharmaceutical market, and public demand for drugs with similar effects at low prices also affected the popularity of fake drugs. Hence, the distribution of fake medicine in the Qing society can be seen as a phenomenon of separation between the prescription and distribution of drugs, commercialization and consumption of drugs, and competition on the medical market.

참고문헌 (46)

  1. 長孫無忌, "唐律疏義注譯, 卷18" (2016), 甘肅人民出版社
  2. 陶弘景, "本草經集注 卷1" (1994), 人民衛生出版社
  3. 李之彥, "全宋筆記, 第8編4" (2017), 大象出版社
  4. 樓含松, "中國曆代家訓集成 2" (2017), 浙江古籍出版社
  5. 竇儀, "宋刑統, 卷26" (1999), 法律出版社
  6. 賈所學, "藥品化義" (2012), 中醫古籍出版社
  7. 李時珍, "本草綱目 卷1" (2008), 華夏出版社
  8. 陳嘉謨, "本草蒙筌" (2008), 中醫古籍出版社
  9. 薑衍澤堂, "薑衍澤堂發記丸散膏丹錄" (2017), 北京科學技術出版社
  10. 戴新民, "本草便讀" (1981), 啟業書局
  11. 徐珂, "清稗類鈔 11" (1986), 中華書局
  12. 徐靈胎, "醫學源流論" (2008), 中國中醫藥出版社
  13. 樂鈞, "三異筆談" (1996), 重慶出版社
  14. 樂鳳鳴, "同仁堂藥目" (2010), 北京學苑出版社
  15. 俞樾, "春在堂全書 第3冊" (2010), 鳳凰出版社
  16. 吳鞠通, "醫醫病書點注" (2007), 中醫古籍出版社
  17. 吳趼人, "二十年目睹之怪現狀" (2018), 華文出版社
  18. 陳弘謀, "五種遺規 20" (2015), 線裝書局
  19. 許仲元, "『偽藥致誤』, 樂鈞, 『三異筆談』 卷4" (1996), 重慶出版社
  20. 江蘇省博物館, "江蘇省明清以來碑刻資料選集" (1959), 生活·讀書·新知三聯書店
  21. 平江區志編纂委員會, "平江區志" (2006), 上海社會科學院
  22. "『黃帝內經素問』 卷8, 「寶命全形論」" (1997), 中醫古籍出版社
  23. "『清實錄』 第16冊, 『清高宗純皇帝實錄』 8卷" (1986), 中華書局
  24. "大淸光緖新法令", ~
  25. 曲彥斌, "中國隱語行話大辭典" (1995), 遼寧教育出版社
  26. 金久寧, "胡慶餘堂丸散膏丹全集" (2017), 中國中醫藥出版社
  27. 金老佛, "三教九流江湖秘密規矩" (1990), 河北人民出版社
  28. 唐廷猷, "中國藥業史" (2013), 中國醫藥科技出版社
  29. 樊波, "民國衛生法制硏究", 博士, pp.2012
  30. 範金民, "明清商事糾紛與商業訴訟" (2007), 南京大學出版社
  31. 邊和, "新史學(第9卷)" (2017), 中華書局
  32. 安冠英, "中華百年老藥鋪, 華東卷" (1993), 中國文史出版社
  33. 梁其姿, "面對疾病——傳統中國社會的醫療觀念與組織" (2012), 中國人民大學出版社
  34. 余新忠, "清代江南的瘟疫與社會 : 一項醫療社會史的研究" (2003), 中國人民大學出版社
  35. 王雨濛, "刀針, 膏貼與湯藥:清代的外科", 碩士, pp.2013
  36. 龍伯堅, "現存本草書錄" (1957), 人民衛生出版社
  37. 張磊, "清代北京中醫醫療模式研究", 博士, pp.2007
  38. 張仲民, "晚清上海藥商的廣告造假現象探析", 中央研究院近代史研究所集刊, 85 (2014)
  39. 張仲民, "當糖精變爲燕窩—孫鏡湖與近代上海的醫藥廣告文化", 社會科學研究, (1) (2017)
  40. 狄鴻旭, "清代基層社會官方醫療機構初探——以華北方志爲中心", 中華中醫藥學會第十六次醫史文獻分會學術年會暨新安醫學論壇 (2014)
  41. 狄鴻旭, "清代“醫學署”初探", 滿族研究, 2 (2015)
  42. 田代華, "中醫攬勝" (1992), 山東科學技術出版社
  43. 鄭曼青, "中華醫藥學史" (1982), 台灣商務印書館股份有限公司
  44. 周旭霞, "三百年國醫國藥館—方回春堂" (2016), 浙江工商大學出版社
  45. 陳秀瑗, "中藥炮製技術" (2017), 中國醫藥技術出版社
  46. 黃鑫, "『同仁堂藥目』和清末藥肆的官司", 中華醫史雜誌, 34(3) (2004)

관련 논문AI추천

이 간행물의 다른 논문 (4건)